Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMontefiore Medical Center

About this trial

The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on this topic are scarce. Particularly, little is known about which patients are at greatest risk of procedural complications, such as the timing and onset of conduction disturbances necessitating permanent pacemaker implantation, and how such patients are managed. On this background, the TRIPLACE Registry - an investigator-initiated global multicenter registry - is aimed at better understanding the safety and efficacy of orthotopic TTVR.

Eligibility criteria

Qualifiers

Patients undergoing Transcatheter Tricuspid Valve Replacement

Native Tricuspid Valve disease

Orthotopic Tricuspid Valve Implantation

Disqualifiers

Age under 18 years

Trial design

Treatments tested in this trial

  • Transcatheter Tricuspid Valve Replacement

Treatment groups

800 Participants
are divided into 1 treatment group

Sponsors and collaborators

Montefiore Medical Center

Lead sponsor

The Cleveland Clinic

Collaborator

University of Toronto

Collaborator

University Hospital, Bordeaux

Collaborator